To test thermal stability, the enzyme was incubated in a water bath for 30 min and the remaining activity was then measured at 25 °C, using the method previously described for BApNA. The inhibition tests were performed using the methodology adapted by Bezerra et al. (2005). A 30 μl sample of the purified enzyme was incubated in microplates for 30 min with 30 μl of different peptidase inhibitors whilst maintaining a final concentration of 2 mM. The inhibitors used in this test were ethylene diamine tetra-acetic acid – EDTA (metallopeptidase inhibitor), β-mercaptoethanol (reducing

agent), phenylmethylsulphonyl fluoride – PMSF (serine peptidases inhibitor), benzamidine (trypsin inhibitor), tosyl lysine chloromethyl ketone

– TLCK (trypsin inhibitor) and tosyl phenylalanyl chloromethyl ketone Alisertib ic50 – TPCK (chymotrypsin inhibitor). After incubation, 110 μl of Tanespimycin cost buffer 0.1 M Tris–HCl and 30 μl of BApNA were then added. After 10 min, the absorbance reading was performed in microplate reader (BioRad xMarktm) at a wavelength of 405 nm. Aliquots of 30 μl of the purified enzyme were incubated with 30 μl of various metals (AlCl3, BaCl2, CaCl2, CdCl2, CuCl2, FeCl2, HgCl2, KCl, LiCl, MnCl2, PbCl2, ZnCl2) for 30 min in microplates with final concentration of 1 mM. Next, 110 μl of 0.1 M Tris–HCl, pH 8.0, and 30 μl of the substrate BApNA were added. After 10 min of reaction, enzyme activity was measured in a microplate reader at 405 nm.

Atazanavir The substrate used in the kinetic test was BApNA (final concentration from 0 to 4.8 mM), prepared with DMSO. The reaction was performed in triplicate in microplates and consisted of a mixture of a 30 μl solution of purified enzyme (109 μg protein ml−1) with 140 μl of 0.1 M Tris–HCl, pH 8.0 and 30 μl of substrate. The release of the product (p-nitroaniline) was monitored by a microplate reader at 405 nm. The activity values (U s−1) obtained for each substrate concentration were plotted on a graph and the Michaelis–Menten asymptotic kinetic parameters (Vmax and Km) were calculated using the MicrocalTM OriginTM program version 6.0 (Software Inc., USA). The purified trypsin was sequenced at the Biochemistry Laboratory of the Escola Paulista de Medicina, Universidade Federal de São Paulo (Brazil). The NH2-terminal amino acid sequence was obtained through Edman degradation using a PPSQ-23 sequencer (Shimadzu, Tokyo, Japan). The NH2-terminal amino acid sequence obtained for the present study was aligned with other’s sequences using the software BioEdit Sequence Alignment Editor (Hall, 1999). All data was analysed using one-way analysis of variance (ANOVA) complemented with Tukey’s test. Differences were reported as statistically significant when p < 0.05. The statistical program used was MicrocalTM OriginTM version 8.0 (Software, Inc., US). A trypsin from the pyloric caeca and intestine of the silver mojarra (D.